SPINK9 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-45835
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, ELISA
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
serine peptidase inhibitor, Kazal type 9. (Uniprot# Q5DT21)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
Novus Biologicals Rabbit SPINK9 Antibody - BSA Free (NBP3-45835) is a polyclonal antibody validated for use in IHC and ELISA. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for SPINK9 Antibody - BSA Free
Immunohistochemistry: SPINK9 Antibody - BSA Free [NBP3-45835] -
Immunohistochemistry: SPINK9 Antibody - BSA Free [NBP3-45835] - Immunohistochemistry of paraffin-embedded human liver tissue slide using ( SPINK9 Antibody) at dilution of 1:200Applications for SPINK9 Antibody - BSA Free
Application
Recommended Usage
Immunohistochemistry
1:20-1:200
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS, 50% Glycerol, pH (7.3)
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: SPINK9
Alternate Names
LEKTI2, lymphoepithelial Kazal-type-related inhibitor 2, serine peptidase inhibitor, Kazal type 9, serine protease inhibitor Kazal type 9
Gene Symbol
SPINK9
Additional SPINK9 Products
Product Documents for SPINK9 Antibody - BSA Free
Product Specific Notices for SPINK9 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...